SEC EDGAR · Insider purchase
AGMB: Epstein David R reported buying shares
3 reported purchases of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow AGMB- Became public
- Nov 6, 2026
- Event / period date
- Nov 5, 2026
- Collected
- Nov 8, 2026, 9:16 AM EST
Why this is connected
This filing identifies AgomAb Therapeutics NV as the issuer of the security. The company's SEC identifier connects it to AGMB.
Reported transactions
Epstein David R (Director)
5,000 shares · Common shares
Nov 5, 2026 · $6.81 per share
5,000 shares · Common shares
Nov 5, 2026 · $6.91 per share
5,000 shares · Common shares
Nov 5, 2026 · $6.98 per share
Value calculated from the reported shares and prices: $103,500.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-05</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0002020932</issuerCik>
<issuerName>AgomAb Therapeutics NV</issuerName>
<issuerTradingSymbol>AGMB</issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001445826</rptOwnerCik>
<rptOwnerName>Epstein David R</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>true</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>C/O AGOMAB THERAPEUTICS NV</rptOwnerStreet1>
<rptOwnerStreet2>POSTHOFLEI 1/6</rptOwnerStreet2>
<rptOwnerCity>ANTWERP</rptOwnerCity>
<rptOwnerNonUSStateTerritory></rptOwnerNonUSStateTerritory>
<rptOwnerCountry>C9</rptOwnerCountry>
<rptOwnerZipCode>2600</rptOwnerZipCode>
<rptOwnerStateDescription>BELGIUM</rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>1</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>0</isTenPercentOwner>
<isOther>0</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common shares</value>
<footnoteId id="F1"/>
</securityTitle>
<transactionDate>
<value>2026-11-05</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>5000</value>
</transactionShares>
<transactionPricePerShare>
<value>6.81</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>30000</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeTransaction>
<securityTitle>
<value>Common shares</value>
<footnoteId id="F1"/>
</securityTitle>
<transactionDate>
<value>2026-11-05</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>5000</value>
</transactionShares>
<transactionPricePerShare>
<value>6.91</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>35000</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeTransaction>
<securityTitle>
<value>Common shares</value>
<footnoteId id="F1"/>
</securityTitle>
<transactionDate>
<value>2026-11-05</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>5000</value>
</transactionShares>
<transactionPricePerShare>
<value>6.98</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>40000</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">The common shares may be represented by American Depositary Shares, each of which currently represents one common share.</footnote>
</footnotes>
<ownerSignature>
<signatureName>/s/ Ellen Lefever, Attorney-in-fact</signatureName>
<signatureDate>2026-11-06</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.